CLINICAL SCIENCE FOCUS SESSION: Assessment of Prostate Cancer

Room 602 - 604         14:00 - 16:00                 Chairs: N. R. Jagannathan and Daniel B. Vigneron


Prog #

14:00 109.

Dynamic Contrast Enhanced Imaging and Quantitative Analysis of Prostate Cancer at 3 Tesla

Iclal Ocak1, Marcelino Bernardo2, Gregory Metzger3, 4, Yolanda McKinney5, Peter Choyke1

1National Cancer Institute, Bethesda, Maryland, USA; 2SAIC-Frederick, Frederick, Maryland, USA; 3Philips Medical Systems, Bethesda, Maryland, USA; 4University of Minnesota, Bethesda, Maryland, USA; 5National Institute of Health, Bethesda, Maryland, USA
14:10 110.

Analysis of Prostate DCE-MRI at 3T Using a Measured Arterial Input Function

Martin Lowry1, Lindsay W. Turnbull1

1University of Hull, Hull, UK
14:20 111.

MRI-Guided Prostate Biopsy for Individuals with Elevated or Increasing PSA Levels After Negative TRUS-Biopsy

Matthias Philipp Lichy1, Aristotelis Anastasiadis1, Arnulf Stenzl1, Claus D. Claussen1, Heinz-Peter Schlemmer1

1University of Tuebingen, Tuebingen, BW, Germany
14:30 112.

Ferumoxtran-10 Enhanced MRI in Noninvasive Detection of Lymph Node Metastases; First Results in the Work-Up of

Prostate Cancer in a Clinical Setting

Alette Wilhelmina Daniels-Gooszen1, Roel Heesakkers2, Harrie Van den Bosch1, John Wondergem1, Evert Koldewijn1, Ad Hendrikx1,

Jelle Barentsz2

1Catharina Hospital, Eindhoven, Netherlands; 2UMC St Radboud, Nijmegen, Netherlands
14:40 113.

3D 1H-MR Spectroscopic Imaging of the In Vivo Human Prostate at 3T with a Body Array Coil: A Step Towards MR

Screening of Prostate Cancer?

Tom WJ Scheenen1, Stijn WTPJ Heijmink1, Stefan A. Roell2, Christina A. Hulsbergen-Van de Kaa1, Jelle O. Barentsz1, Arend


1Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; 2Siemens Medical Solutions, Erlangen, Germany
14:50 114.

Potential of 3D 1H MRSI and DWI in Men with Increased PSA

Virendra Kumar1, N R. Jagannathan1, Rajeev Kumar1, S C. Das1, Lokesh Jindal1, Sanjay Thulkar1, S Dutta Gupta1,

S N. Dwivedi1, Stefan Roell2, A K. Hemal1, N P. Gupta1

1All India Institute of Medical Sciences, New Delhi, India; 2Siemens, Erlangen, Germany
15:00 115.

Intermediate Results of IMAPS: An International Multi-Centre Assessment of Prostate MR Spectroscopy

Tom Scheenen1, Elisabeth Weiland S Roell2, Paul van Hecke3, Marc Lemort4, Peter Bachert5, Heinz-Peter Schlemmer6, Jaoping Lu7,

Dale Broome8, Geert Villeirs9, Jurgen Futterer J Barentsz A Heerschap1

1Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; 2Siemens Medical Solutions, Erlangen, Germany; 3University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium; 4Jules Bordet Institute, Brussels, Belgium; 5German Cancer Research Institute DKFZ, Heidelberg, Germany; 6University of Tuebingen, Tuebingen, Germany; 7Shanghai Changhai Hospital, Shanghai, People’s Republic of China; 8Loma Linda University Health Science Centre, Loma Linda, California, USA; 9University Hospital Ghent, Ghent, Belgium
15:10 116.

Combined Use of Endorectal MRS and Apparent Diffusion Coefficients to Increase Accuracy in Prostate Tumour Detection

Stefan A. Reinsberg1, 2, Geoffrey S. Payne1, Sophie F. Riches1, Sue Ashley3, Nandita M. deSouza1

1Institute of Cancer Research, Sutton, Surrey, UK; 2University of British Columbia, Vancouver, BC, Canada; 3Royal Marsden NHS Trust, Sutton, Surrey, UK
15:20 117.

A Study of Differentiation Between Prostate Cancer and Prostatitis by 1H MR Spectroscopic Imaging (MRSI)

Saying Li1, Haodan Dang1, Wenchao Wang1, Chen Zhang1, Cheng zhou1, Min Chen1

1Beijing Hospital, Beijing, People’s Republic of China
15:30 118.

Signal Loss in DCE-MRI Associated with Tumor Progression in Prostate Cancer Bone Metastasis Model

Hagit Dafni1, Sun Jin Kim1, Kunal Panda1, James A. Bankson1, Sabrina M. Ronen1

1The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA

15:40 119.

Correlation of Choline-Containing Metabolites with Gene Expression of Kennedy Cycle Enzymes

John Kurhanewicz1, Carissa Ferrer Santos1, Thomas Nordling Butler1, David Jae-hyeun Joun1, Sarah J. Nelson1,

Daniel B. Vigneron1, Mark Gunnard Swanson1

1UCSF, San Francisco, California, USA
15:50 120.

Characterizing the Physiological Environments of a Prostate Cancer Xenograft in Orthotopic and Subcutaneous Sites

Zaver M. Bhujwalla1, Arvind P. Pathak1, Meiyappan Solaiyappan1, Venu Raman1, Paloma Ballesteros2, Dmitri Artemov1

1The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 2UNED, Madrid, Spain